Linda Greub

Linda Greub, CFA, MBA, currently serves as a Board Member for Clarified Precision Medicine, Madorra Inc., Mae, and holds the position of Board Observer for AmplifiDx and Raydiant Oximetry, Inc. Since October 2018, Linda has been Managing Partner at Avestria Ventures, focusing on investments in early-stage women's health and life science ventures. Previous roles include CEO at Muir Partners, where Linda specialized in life science consulting and financial advisory, and Partner at LMN Ventures, LLC, providing seed capital to early-stage companies. Additional experience includes VP Corporate Development at RainDance Technologies and VP Strategy & Corporate Development at Singulex. Linda's educational background includes an MBA from Harvard Business School and extensive executive training at institutions such as Stanford Graduate School of Business and Harvard Law School, as well as ongoing education in artificial intelligence in health care at MIT.